Innovation Park Basel Area

Innovation Log

View of Switzerland Innovation Park Basel Area in Allschwil

Allschwil – Birthplace of ground-breaking life sciences companies

Located in the midst of the Life Sciences Cluster Basel, Allschwil is a great location for aspiring start-ups, spin-offs or research groups from all over the world.

When planning to start a company, choosing the right location is obviously one of the key elements to success. Greater Basel offers excellent conditions for all ventures in the biotech, medtech and pharmaceutical industries. The city of Allschwil combines the benefits of an ambitious yet traditional suburban community with the proximity to Basel and the advantages of one of the world’s leading life sciences clusters with all its academic institutions, up to 700 life sciences companies and a considerable international pool of 33’000 life sciences talents to recruit from.

Successful companies started in Allschwil

Actelion Headquarters in Allschwil
Actelion headquarters in Allschwil (©Mathias Mangold)

Several internationally successful companies were originally started in Allschwil or have headquarters here. Actelion, for example, a true poster child start-up, was founded in 1997 as a biopharmaceutical spin-off from F. Hoffmann-La Roche. The team literally started from scratch. Today, Actelion has around 2500 employees in more than 25 countries. Even though the company was acquired by US-based Johnson & Johnson recently, the global headquarters remain in Allschwil. American health care giant Abbott (with approximately 100’000 employees around the world) maintains its international center for generic pharmaceuticals in Allschwil. Viollier, a highly successful family-owned enterprise specialized in analyses and diagnostics, built its first of today’s three laboratories in Allschwil in the nineties.

One of the latest players to take residence in Allschwil is Idorsia: the drug development company was demerged from Actelion in summer 2017 and now has an experienced team of highly qualified professionals as well as a full R&D pipeline. The majority of these corporations are based in Allschwil’s Bachgraben quarter with its already existing and planned impressive, innovative architecture that in particular is marked by the outstanding designs of Herzog & De Meuron. The future of the quarter looks bright and new state-of-the art offices and labs are currently under development.

Allschwil – the best of both worlds

Plug'n'play labs at Switzerland Innovation Park Basel Area
Plug & play labs at Switzerland Innovation Park Basel Area (©Jochen Pach)

On the one hand, Allschwil fosters all the typical attributes of swissness. It provides security, reliable public transportation, dependable infrastructure and easy-to-reach recreational areas in the countryside. On the other hand, the city of Basel with its cosmopolitan vibrancy and large expat community is only a 10-minute tram ride away.

The convenient location also proves to be a big plus for companies: Allschwil is easily accessible for visitors coming in by plane, car or train – without having to go through the inner-city traffic or parking. The international airport can be reached within 15 minutes, just as the train station with excellent connections into all of Europe. A direct tram further connects Allschwil with the neighboring France and Germany.

If you would like to find out more, we can assure you Allschwil and the Basel region are definitely worth a visit.

This article represents the first of a series about the life sciences hotspot Allschwil.

Leave a Comment:

«You may also like»

SWITZERLAND INNOVATION PARK BASEL AREA PRESENTS ITS LATEST ARRIVALS

The Park Basel Area community is growing – we are delighted to present our new residents.…> Read more

Register for the DBE Research Day 2018

On September 5, 2018, the Department of Biomedical Engineering (DBE) is open to the public. Guests,…> Read more
Predemtec at Switzerland Innovation Park Basel Area is focused on research, development and manufacture of innovative diagnostic tests for use in the detection of Alzheimer-related risk factors

Early Diagnosis for Alzheimer’s Disease

Despite all efforts, science has not yet found an effective way to treat Alzheimer's disease. Predemtec…> Read more